These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18161829)

  • 1. Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence.
    Rosen HR; Doherty DG; Madrigal-Estebas L; O'Farrelly C; Golden-Mason L
    Liver Transpl; 2008 Jan; 14(1):31-40. PubMed ID: 18161829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
    Golden-Mason L; Madrigal-Estebas L; McGrath E; Conroy MJ; Ryan EJ; Hegarty JE; O'Farrelly C; Doherty DG
    Gut; 2008 Aug; 57(8):1121-8. PubMed ID: 18372499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C.
    Leroy V; Vigan I; Mosnier JF; Dufeu-Duchesne T; Pernollet M; Zarski JP; Marche PN; Jouvin-Marche E
    Hepatology; 2003 Oct; 38(4):829-41. PubMed ID: 14512870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
    Jain A; Ryan C; Mohanka R; Orloff M; Abt P; Romano J; Bryan L; Batzold P; Mantry P; Bozorgzadeh A
    Clin Transplant; 2006; 20(5):624-33. PubMed ID: 16968489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.
    Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K
    Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantation.
    Weston SJ; Leistikow RL; Reddy KR; Torres M; Wertheimer AM; Lewinsohn DM; Chou S; Davey MP; Corless C; O'Farrelly C; Nelson DR; Rosen HR
    Hepatology; 2005 Jan; 41(1):72-81. PubMed ID: 15619226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
    Tseng CT; Miskovsky E; Houghton M; Klimpel GR
    Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.
    Zarife MA; Reis EA; Carmo TM; Lopes GB; Brandão EC; Silva HR; Santana N; Martins-Filho OA; Reis MG
    J Med Virol; 2009 Jan; 81(1):49-59. PubMed ID: 19031471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
    Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O
    Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells.
    Agrati C; Nisii C; Oliva A; D'Offizi G; Montesano C; Pucillo LP; Poccia F
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):307-16. PubMed ID: 12455864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.
    Varchetta S; Oliviero B; Francesca Donato M; Agnelli F; Rigamonti C; Paudice E; Arosio E; Berra M; Rossi G; Tinelli C; Fagnoni FF; Colombo M; Mavilio D; Mondelli MU
    J Hepatol; 2009 Feb; 50(2):314-22. PubMed ID: 19070924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection.
    Inoue M; Kanto T; Miyatake H; Itose I; Miyazaki M; Yakushijin T; Sakakibara M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Hepatol; 2006 Aug; 45(2):190-6. PubMed ID: 16580086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.
    Bonilla N; Barget N; Andrieu M; Roulot D; Letoumelin P; Grando V; Trinchet JC; Ganne-Carrié N; Beaugrand M; Deny P; Choppin J; Guillet J; Ziol M
    J Viral Hepat; 2006 Jul; 13(7):474-81. PubMed ID: 16792541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrochimerism of donor type CD56+ CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Abo T; Hatakeyama K
    Hepatogastroenterology; 2003; 50(54):2161-5. PubMed ID: 14696487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of hepatitis C virus specific immune responses in anti-HCV positive patients without hepatitis C viremia.
    Yao P; Hu X; Hu D
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):227-30. PubMed ID: 11498684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.